5-HT2B RECEPTOR ANTAGONISTS

Details for Australian Patent Application No. 2003207299 (hide)

Owner PHARMAGENE LABORATORIES LIMITED

Inventors CLARK, Kenneth, Lyle; OXFORD, Alexander, William; BORMAN, Richard, Anthony; COLEMAN, Robert, Alexander

Pub. Number AU-A-2003207299

PCT Number PCT/GB03/00567

PCT Pub. Number WO2003/068227

Priority 60/358,716 25.02.02 US; 0203413.0 13.02.02 GB

Filing date 11 February 2003

Wipo publication date 4 September 2003

International Classifications

A61K 031/425 - Thiazoles

A61P 001/00 Drugs for disorders of the alimentary tract or the digestive system

C07D 277/40 Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

Event Publications

17 July 2003 Complete Application Filed

  Priority application(s): 60/358,716 25.02.02 US; 0203413.0 13.02.02 GB

2 October 2003 Application Open to Public Inspection

  Published as AU-A-2003207299

29 June 2006 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003207300-INFORMATION ROUTING

2003207298-Nicotinamide derivates useful as p38 inhibitors